Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies

Wladimir Mauhin (1, 2) , Kuberaka Mariampillai (1, 2) , Yves Allenbach (2, 1) , Jean-Luc Charuel (1) , Lucile Musset (1) , Olivier Benveniste (2, 1)

1 CHU Pitié-Salpêtrière [AP-HP]
2 Centre de recherche en Myologie – U974 SU-INSERM

Anti‐mitochondrial antibodies type 2 (AMA2) are the hallmarks of primary biliary cholangitis (PBC) [1]. AMA2 have also been described in 11.3% of idiopathic inflammatory myopathies (IIM) then associatedwith cardiac involvement, muscular atrophy and granuloma (table 1) [2].

Mots clés: anti‐mitochondrial antibodies; myositis; auto‐antibodies; primary biliary cholangitis

Domaines: Immunologie

Wladimir Mauhin, Kuberaka Mariampillai, Yves Allenbach, Jean-Luc Charuel, Lucile Musset, et al.. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies. Joint Bone Spine, 2017, ⟨10.1016/j.jbspin.2017.04.004⟩. ⟨hal-01518320⟩